Symposium 1 The Impact of social media in Liver Disease Research and Education – Is it time to embrace this more widely?
Wednesday, April 26 | 8:30 – 10:30
Moderators: Juan Pablo Arab (Canada) & EASL: Ahmed Elsharkawy (UK)
- What do I gain from my involvement in social media – the viewpoint of a senior academic
(8:30 – 8:50)
AASLD: Juan Pablo Arab, University of Wester Ontario (Canada)
- Medical Education Opportunities in social media – Tweetorials, journal clubs and more
(8:50 – 9:10)
AASLD: Elliot B. Tapper, University of Michigan Medical Center
- An Editor’s View on the role of social media in the dissemination of research findings
(9:10 – 9:30)
EASL: Jean-Charles Nault (France)
- Medical social media and the ‘Echo Chamber’ – the good, the bad and the ugly
(9:30 – 9:50)
EASL: Walter Quattrociocchi (Italy)
- Debate: HCPs have a moral obligation to be involved in social media to counteract disinformation
(9:50 – 10:05)
For: Philipp Schwabl, Medical University of Vienna (Austria)
Against: Ahmed Elsharkawy (UK)
- Panel Discussion
(10:05 – 10:20)
Symposium 2 Disparities in Liver Cancer
Wednesday, April 26 | 14:00 – 16:00
Moderators: AASLD – Juan Pablo Arab, University of Western Ontario & EASL – Jean Charles Nault, Avicenne Hospital, APHP
PART 1
- Introductions
(14:00 – 14:05)
- Disparities in implementation of screening guidelines
(14:05 – 14:25)
EASL: Manon Allaire, Pitié Salpetrière Hospital (France)
- Disparities and treatment outcomes
(14:25 – 14:45)
AASLD: Fasiha Kanwal, Michael E. DeBakey VA Medical Center (USA)
- Q&A / Joint Panel EASL & AASLD
(14:45 – 15:05)
PART 2
- HCV Screening in underserved cohorts at high risk for HCC
(15:05 – 15:25)
AASLD: Norah Terrault, University of Southern California (USA)
- Impact of social determinants of health on HCC outcomes
(15:25 – 15:45)
EASL: Charlotte Costentin (Grenoble)
- Q&A / Joint Panel AASLD & EASL
(15:45 – 16:00)
